China Medical City, located in Taizhou, an important node city in the Yangtze River Delta, has a total planned area of 30 square kilometers and is composed of functional areas such as scientific research and development zone, manufacturing zone, convention and exhibition trading zone, health medical district, education and teaching area and comprehensive supporting zone. China's first state-level high-tech medical and pharmaceutical zone is jointly constructed by the Ministry of Science and Technology, the State Health and Family Planning Commission, the State Food and Drug Administration, the State Administration of Traditional Chinese Medicine and Jiangsu Provincial People's Government.

At present, the Park has gathered more than 60 well-known domestic and foreign universities and pharmaceutical R & D institutions. Nearly 800 well-known domestic and foreign pharmaceutical enterprises such as Nestle, AstraZeneca, Takeda Pharmaceutical, Boehringer Ingelheim, Shijiazhuang Pharmaceutical Group and Neptunus Pharmaceutical have set up successively; A number of "world-class, domestic-leading" achievements in medical innovation successfully applied for landing; more than 2,800 high-level talents at home and abroad settled down in the business, 45 were selected for the national "Thousand Talents Program"; was included in the national new vaccines and specific diagnostic reagents industry Agglomeration area development pilot; start the development area of 18 square kilometers.

China Medical City is striding forward in the wave of biomedicine in the world. It is also embarking on embracing various innovative medical resources and endeavoring to build the first city in China's pharmaceutical industry.